CM
SRPT icon

Caption Management’s Sarepta Therapeutics SRPT Stock Holding History

Caption Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Hold
50,000
– – 0.01% 1001
2025
Q4 		$1.08M Sell
50,000
-121,500
-71% -$2.56M 0.01% 1034
2025
Q3 		$3.3M Sell
171,500
-14,700
-8% -$262K 0.03% 638
2025
Q2 		$3.18M Buy
+186,200
New +$7.94M 0.04% 560
2025
Q1 		– Sell
-85,000
Closed -$10.3M – 2007
2024
Q4 		$10.3M Buy
85,000
+45,000
+113% +$5.51M 0.1% 187
2024
Q3 		$5M Sell
40,000
-62,900
-61% -$8.7M 0.08% 295
2024
Q2 		$16.3M Buy
102,900
+23,100
+29% +$2.97M 0.25% 85
2024
Q1 		$10.3M Sell
79,800
-89,300
-53% -$10.9M 0.16% 158
2023
Q4 		$16.3M Sell
169,100
-227,400
-57% -$21.8M 0.22% 114
2023
Q3 		$48.1M Buy
396,500
+203,900
+106% +$23M 0.74% 15
2023
Q2 		$22.1M Sell
192,600
-75,000
-28% -$9.67M 0.39% 50
2023
Q1 		$36.9M Sell
267,600
-41,700
-13% -$5.41M 0.71% 21
2022
Q4 		$40.1M Buy
309,300
+71,100
+30% +$8.24M 0.63% 23
2022
Q3 		$26.3M Buy
238,200
+132,500
+125% +$13.4M 0.36% 49
2022
Q2 		$7.92M Buy
105,700
+105,000
+15,000% +$7.72M 0.11% 238
2022
Q1 		$55K Sell
700
-339,300
-100% -$26M ﹤0.01% 1359
2021
Q4 		$30.6M Buy
+340,000
New +$29.1M 0.34% 45
2021
Q3 		– Sell
-58,800
Closed -$4.57M – 1788
2021
Q2 		$4.57M Buy
+58,800
New +$4.46M 0.06% 390
2021
Q1 		– Sell
-57,500
Closed -$9.8M – 1373
2020
Q4 		$9.8M Sell
57,500
-37,500
-39% -$5.56M 0.22% 122
2020
Q3 		$13.3M Buy
95,000
+73,800
+348% +$11.2M 0.31% 68
2020
Q2 		$3.4M Hold
21,200
– – 0.11% 242
2020
Q1 		$2.07M Hold
21,200
– – 0.12% 245
2019
Q4 		$2.74M Buy
+21,200
New +$2.14M 0.09% 299
2019
Q3 		– Sell
-35,000
Closed -$5.32M – 876
2019
Q2 		$5.32M Buy
35,000
+15,000
+75% +$1.82M 0.27% 107
2019
Q1 		$2.38M Buy
+20,000
New +$2.57M 0.13% 209

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caption Management's SRPT Position: Q1 2026 in Review

Caption Management increased its Sarepta Therapeutics (SRPT) stake by 42% in Q1 2026, buying an estimated $329K and bringing the position to 57,890 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #947.

Caption Management first reported a position in SRPT in Q1 2019 and has held it in 13 quarters since. The position peaked at $35.9M in Q2 2024. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Caption Management held 57,890 shares of Sarepta Therapeutics worth $1.26M as of Q1 2026.
  • Caption Management bought 17,000 Sarepta Therapeutics shares in Q1 2026, an estimated $329K.
  • Sarepta Therapeutics made up 0.01% of Caption Management's portfolio in Q1 2026, its #947 holding.
  • Caption Management first reported a position in Sarepta Therapeutics in Q1 2019 and has held it in 13 quarters since.
  • Caption Management's Sarepta Therapeutics position peaked at $35.9M in Q2 2024.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.